Early IL-1 inhibition and long-term remission in childhood-onset Still's disease: a real-world cohort study - Top-Institutions - MDSpire

Early IL-1 inhibition and long-term remission in childhood-onset Still's disease: a real-world cohort study

  • By

  • Burcu Bozkaya Yücel

  • Seyda Dogantan

  • Semanur Ozdel

  • Özlem Aydoğ

  • June 15, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatrics
    • Rheumatology

  • #2

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatrics
    • Rheumatology

Original Source(s)

Early IL-1 inhibition and long-term remission in childhood-onset Still's disease: a real-world cohort study

  • by Burcu Bozkaya Yücel, Seyda Dogantan, Semanur Ozdel, Özlem Aydoğ

  • June 15, 2026

Related Content

Real-world effectiveness and safety of dupilumab therapy in children ≤6 years with uncontrolled persistent asthma: a propensity-matched retrospective cohort study

Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers

Clinical and genotypic analysis of 79 children with methylmalonic acidemia: a retrospective single-center study in China